Skip to main content
. Author manuscript; available in PMC: 2020 Jan 9.
Published in final edited form as: Oncogene. 2019 Jul 9;38(34):6159–6171. doi: 10.1038/s41388-019-0870-y

Table 1:

Summary of oHSVs

Virus Deletion/Mutation Foreign gene/promoter insertion Reference
C130 Deletion in both copies of γ134.5 gene Expresses the HCMV TRS1 gene product (43)

C134 Deletion in both copies of γ134.5 gene IRS1 gene under control of an HCMV immediate early promoter (43, 44, 60)

dlsptk Thymidine-kinase deficient None (7)

G207 Deletion in both copies of γ134.5 gene and disabling lacZ insertion in UL39 None (6, 8, 16, 17, 24, 30, 37, 51, 89)

G47∆ Deletion of the γ134.5 and α47 genes and a disabling lacZ insertion within ICP6 Murine angiostatin (14, 20, 75)

G47∆-IL12 Deletion of the γ134.5 and α47 genes and a disabling lacZ insertion within ICP6 Murine IL-12 gene insert (72, 73, 85)

HSV1716 Deletion in both copies of γ134.5 gene None (912, 23)

M002 Deletion in both copies of γ134.5 gene Murine IL-12 gene insert (30, 67, 68, 70)

M032 Deletion in both copies of γ134.5 gene Human IL-12 gene insert (71)

NG34 Deletion in ICP6 and ICP34.5 genes Human GADD34 gene transcriptionally controlled by the Nestin promoter (41)

R-115 None Murine IL-12; CMV promoter (36)

R5141 Deletion of polylysine tract in gB Insertion of IL-13 between amino acids 24 and 25 of gD (38)

R5181 Deletion of polylysine tract in gB Insertion of urokinase plasminogen activator between amino acids 24 and 25 of gD (39)

RAMBO Deletion in both copies of γ134.5 gene and in-frame gene-disrupting insertion of GFP within ICP6 gene Vasculostatin (Vstat120) under control of the HSV IE 4/5 promoter (74)

rHSVQ1 Deletion in UL39 and γ134.5 genes None (40, 45)

rQNestin34.5v.2 Deletion in γ134.5 gene and UL39 ICP-34.5 under control of synthetic nestin promoter (40, 45)

talimogene laherparepvec (T-Vec) Deletions of the ICP34.5 and ICP47 genes Granulocyte-macrophage colony-stimulating factor, CMV promoter (13, 86)